Sanofi partners with OpenAI and Formation Bio to accelerate AI drug discovery

Editor | Accelerating the application of artificial intelligence in drug development.

This collaboration will be a game changer for the pharmaceutical industry. By combining data, artificial intelligence technology and expertise in drug development, they aim to revolutionize the way new medicines are discovered and brought to market.

Sanofi CEO Paul Hudson said:

"This collaboration is our first step in becoming a company powered by artificial intelligence. An important step for pharmaceutical companies."

Brad Lightcap, chief operating officer of OpenAI, said:

"AI has huge potential to accelerate drug development. . We are excited to partner with Sanofi and Formation Bio to help patients by bringing new medicines to market." said Benjamin Liu, co-founder and CEO of Formation Bio.

## "I firmly believe that by combining our strengths, Sanofi, OpenAI and Formation Bio can reimagine drug development in the pharmaceutical industry. The ability to scale with unprecedented productivity and transform the way we serve The speed with which new medicines are delivered to patients."

Sanofi has collaborated on artificial intelligence in recent years with biotech companies such as Owkin, Exscientia, Insilico Medicine, Amunix Pharmaceuticals, Atomwise and Aqemia.

"Sanofi said the three teams will bring together data, software and tuned models to develop customized, specialized solutions across the entire drug development life cycle. Sanofi will leverage this partnership Relationships, providing proprietary data to develop AI models, continues to be the first AI-driven biopharmaceutical company at scale.”

Reference content:

https:/ /techxplore.com/news/2024-05-sanofi-allies-openai-formation-bio.html

https://hitconsultant.net/2024/05/21/sanofi- formation-bio-openai-partner-on-ai-powered-drug-discovery/

https://www.pharmiweb.com/pwtoday-story/sanofi-formation-bio- and-openai-announce-first-in-class-ai-collaboration

The above is the detailed content of Sanofi partners with OpenAI and Formation Bio to accelerate AI drug discovery. For more information, please follow other related articles on the PHP Chinese website!